A randomised phase II trial of the antiemetic effects of Nozinan® compared to a standard dexamethasone containing protocol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN96357650

Enrollment

186

Registered

2003-09-12

Start date

2000-09-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vomiting, delayed chemotherapy-induced emesis (DCIE) Signs and Symptoms Nausea and vomiting

Interventions

Randomised controlled trial comparing (a) study treatment (ie Nozinan®) and (b) standard treatment (ie dexamethasone and Maxolon®).

Eligibility

Inclusion criteria

Inclusion criteria: 196 Patients, 93 in each arm.

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Reduction in emesis.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026